Sp1035

IMPLEMENTING A CURRICULUM FOR ERGONOMICS IN GASTROENTEROLOGY FELLOWSHIP

Date
May 9, 2023
Explore related products in the following collection:

Society: AGA

The Academy of Educators serves to support the careers of educators in GI/Hepatology. Our annual plenary session is an opportunity for those who identify as educators to build skills, strengthen our community, and celebrate the work being done by our junior colleagues. We will have two presentations by expert colleagues on teaching skills and teaching scholarship. Then we will hear from our four grant winners about their ongoing work. There will be opportunities to network with colleagues, learn about the Academy's ongoing projects, and engage with our working groups.

Presenter


Tracks

Related Products

Thumbnail for MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for IMPACT OF HETEROZYGOUS GENETIC VARIANTS IN THE LEPTIN-MELANOCORTIN PATHWAY ON WEIGHT LOSS OUTCOMES FOLLOWING ENDOSCOPIC TRANSORAL OUTLET REDUCTION AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY
IMPACT OF HETEROZYGOUS GENETIC VARIANTS IN THE LEPTIN-MELANOCORTIN PATHWAY ON WEIGHT LOSS OUTCOMES FOLLOWING ENDOSCOPIC TRANSORAL OUTLET REDUCTION AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY
BACKGROUND: Sound evidence support the effectiveness of the transoral outlet reduction (TORe) with full-thickness endoscopic suturing (FTS) or argon plasma coagulation (APC) alone to address post-RYGB weight regain…
Thumbnail for PLACEHOLDER
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…